Logo image of FIVE

FIVE BELOW (FIVE) Stock Fundamental Analysis

USA - NASDAQ:FIVE - US33829M1018 - Common Stock

153.67 USD
-2.38 (-1.53%)
Last: 10/6/2025, 8:16:27 PM
153.67 USD
0 (0%)
After Hours: 10/6/2025, 8:16:27 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to FIVE. FIVE was compared to 122 industry peers in the Specialty Retail industry. FIVE is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. FIVE is valued quite expensive, but it does show an excellent growth. These ratings could make FIVE a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year FIVE was profitable.
FIVE had a positive operating cash flow in the past year.
Each year in the past 5 years FIVE has been profitable.
In the past 5 years FIVE always reported a positive cash flow from operatings.
FIVE Yearly Net Income VS EBIT VS OCF VS FCFFIVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

With a decent Return On Assets value of 5.93%, FIVE is doing good in the industry, outperforming 77.05% of the companies in the same industry.
FIVE has a better Return On Equity (14.32%) than 72.95% of its industry peers.
FIVE's Return On Invested Capital of 7.11% is fine compared to the rest of the industry. FIVE outperforms 68.03% of its industry peers.
The Average Return On Invested Capital over the past 3 years for FIVE is below the industry average of 11.64%.
Industry RankSector Rank
ROA 5.93%
ROE 14.32%
ROIC 7.11%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
FIVE Yearly ROA, ROE, ROICFIVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

FIVE has a Profit Margin of 6.45%. This is amongst the best in the industry. FIVE outperforms 82.79% of its industry peers.
FIVE's Profit Margin has declined in the last couple of years.
FIVE has a better Operating Margin (8.26%) than 80.33% of its industry peers.
In the last couple of years the Operating Margin of FIVE has declined.
FIVE has a Gross Margin (35.06%) which is in line with its industry peers.
FIVE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.26%
PM (TTM) 6.45%
GM 35.06%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
FIVE Yearly Profit, Operating, Gross MarginsFIVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

7

2. Health

2.1 Basic Checks

FIVE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for FIVE has been reduced compared to 1 year ago.
Compared to 5 years ago, FIVE has less shares outstanding
FIVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FIVE Yearly Shares OutstandingFIVE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
FIVE Yearly Total Debt VS Total AssetsFIVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.78 indicates that FIVE is not in any danger for bankruptcy at the moment.
FIVE has a better Altman-Z score (3.78) than 81.15% of its industry peers.
There is no outstanding debt for FIVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.78
ROIC/WACC0.75
WACC9.47%
FIVE Yearly LT Debt VS Equity VS FCFFIVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.71 indicates that FIVE should not have too much problems paying its short term obligations.
FIVE's Current ratio of 1.71 is fine compared to the rest of the industry. FIVE outperforms 76.23% of its industry peers.
FIVE has a Quick Ratio of 1.71. This is a bad value and indicates that FIVE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.85, FIVE is doing good in the industry, outperforming 72.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 0.85
FIVE Yearly Current Assets VS Current LiabilitesFIVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

FIVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.30%, which is quite good.
FIVE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.07% yearly.
Looking at the last year, FIVE shows a quite strong growth in Revenue. The Revenue has grown by 13.88% in the last year.
Measured over the past years, FIVE shows a quite strong growth in Revenue. The Revenue has been growing by 15.99% on average per year.
EPS 1Y (TTM)10.3%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%50%
Revenue 1Y (TTM)13.88%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%23.71%

3.2 Future

FIVE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.76% yearly.
The Revenue is expected to grow by 16.48% on average over the next years. This is quite good.
EPS Next Y3.33%
EPS Next 2Y7.35%
EPS Next 3Y8.72%
EPS Next 5Y30.76%
Revenue Next Year17.4%
Revenue Next 2Y13.54%
Revenue Next 3Y12.11%
Revenue Next 5Y16.48%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
FIVE Yearly Revenue VS EstimatesFIVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
FIVE Yearly EPS VS EstimatesFIVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.59, FIVE can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of FIVE indicates a somewhat cheap valuation: FIVE is cheaper than 63.93% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of FIVE to the average of the S&P500 Index (27.90), we can say FIVE is valued inline with the index average.
The Price/Forward Earnings ratio is 26.46, which means the current valuation is very expensive for FIVE.
FIVE's Price/Forward Earnings is on the same level as the industry average.
FIVE is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.36, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.59
Fwd PE 26.46
FIVE Price Earnings VS Forward Price EarningsFIVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

FIVE's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FIVE indicates a somewhat cheap valuation: FIVE is cheaper than 71.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.55
EV/EBITDA 14.7
FIVE Per share dataFIVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
FIVE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)8.28
PEG (5Y)2.74
EPS Next 2Y7.35%
EPS Next 3Y8.72%

0

5. Dividend

5.1 Amount

No dividends for FIVE!.
Industry RankSector Rank
Dividend Yield N/A

FIVE BELOW

NASDAQ:FIVE (10/6/2025, 8:16:27 PM)

After market: 153.67 0 (0%)

153.67

-2.38 (-1.53%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)12-02 2025-12-02
Inst Owners108.18%
Inst Owner Change0.01%
Ins Owners0.94%
Ins Owner Change-0.15%
Market Cap8.47B
Analysts73.55
Price Target164.19 (6.85%)
Short Float %5.72%
Short Ratio2.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.15%
Min EPS beat(2)3.28%
Max EPS beat(2)29.03%
EPS beat(4)4
Avg EPS beat(4)44.81%
Min EPS beat(4)1.27%
Max EPS beat(4)145.65%
EPS beat(8)5
Avg EPS beat(8)21.71%
EPS beat(12)7
Avg EPS beat(12)22.92%
EPS beat(16)8
Avg EPS beat(16)19.36%
Revenue beat(2)1
Avg Revenue beat(2)-0.09%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)1.37%
Revenue beat(4)2
Avg Revenue beat(4)0.56%
Min Revenue beat(4)-1.55%
Max Revenue beat(4)3.58%
Revenue beat(8)2
Avg Revenue beat(8)-0.86%
Revenue beat(12)3
Avg Revenue beat(12)-0.68%
Revenue beat(16)4
Avg Revenue beat(16)-0.82%
PT rev (1m)1.22%
PT rev (3m)23.4%
EPS NQ rev (1m)46.47%
EPS NQ rev (3m)1460%
EPS NY rev (1m)7.53%
EPS NY rev (3m)9.02%
Revenue NQ rev (1m)1.59%
Revenue NQ rev (3m)4.59%
Revenue NY rev (1m)2.14%
Revenue NY rev (3m)2.82%
Valuation
Industry RankSector Rank
PE 27.59
Fwd PE 26.46
P/S 2
P/FCF 24.55
P/OCF 15.17
P/B 4.44
P/tB 4.44
EV/EBITDA 14.7
EPS(TTM)5.57
EY3.62%
EPS(NY)5.81
Fwd EY3.78%
FCF(TTM)6.26
FCFY4.07%
OCF(TTM)10.13
OCFY6.59%
SpS76.74
BVpS34.58
TBVpS34.58
PEG (NY)8.28
PEG (5Y)2.74
Profitability
Industry RankSector Rank
ROA 5.93%
ROE 14.32%
ROCE 9.49%
ROIC 7.11%
ROICexc 8.7%
ROICexgc 8.7%
OM 8.26%
PM (TTM) 6.45%
GM 35.06%
FCFM 8.16%
ROA(3y)7.16%
ROA(5y)7.3%
ROE(3y)17.41%
ROE(5y)18.22%
ROIC(3y)8.48%
ROIC(5y)9.59%
ROICexc(3y)9.94%
ROICexc(5y)11.39%
ROICexgc(3y)9.94%
ROICexgc(5y)11.39%
ROCE(3y)11.31%
ROCE(5y)12.79%
ROICexcg growth 3Y-24.82%
ROICexcg growth 5Y-8.07%
ROICexc growth 3Y-24.82%
ROICexc growth 5Y-8.07%
OM growth 3Y-21.23%
OM growth 5Y-6.62%
PM growth 3Y-12.57%
PM growth 5Y-7.15%
GM growth 3Y-1.19%
GM growth 5Y-0.89%
F-Score6
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 116.61%
Cap/Sales 5.04%
Interest Coverage 250
Cash Conversion 104.92%
Profit Quality 126.41%
Current Ratio 1.71
Quick Ratio 0.85
Altman-Z 3.78
F-Score6
WACC9.47%
ROIC/WACC0.75
Cap/Depr(3y)229.46%
Cap/Depr(5y)263.43%
Cap/Sales(3y)8.65%
Cap/Sales(5y)9.26%
Profit Quality(3y)40.25%
Profit Quality(5y)53.87%
High Growth Momentum
Growth
EPS 1Y (TTM)10.3%
EPS 3Y0.6%
EPS 5Y10.07%
EPS Q2Q%50%
EPS Next Y3.33%
EPS Next 2Y7.35%
EPS Next 3Y8.72%
EPS Next 5Y30.76%
Revenue 1Y (TTM)13.88%
Revenue growth 3Y10.82%
Revenue growth 5Y15.99%
Sales Q2Q%23.71%
Revenue Next Year17.4%
Revenue Next 2Y13.54%
Revenue Next 3Y12.11%
Revenue Next 5Y16.48%
EBIT growth 1Y-3.55%
EBIT growth 3Y-12.71%
EBIT growth 5Y8.3%
EBIT Next Year60.71%
EBIT Next 3Y25.94%
EBIT Next 5Y30.4%
FCF growth 1Y92.51%
FCF growth 3Y39.02%
FCF growth 5YN/A
OCF growth 1Y27.54%
OCF growth 3Y9.51%
OCF growth 5Y18.16%